Latest Market Strategy News

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Intelligent Monitoring Group delivered a robust Q4 FY25 with $17 million in operating cash flow and plans an on-market share buy-back amid strong earnings growth and strategic acquisitions.

Cromwell Property Group has agreed to sell its 50% stake in a prime Chatswood property for $87 million, aiming to boost FY2026 earnings and reduce debt levels.

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Hazer Group has forged a strategic alliance with engineering giant KBR to fast-track commercial deployment of its methane pyrolysis technology, supported by a $10.7 million capital raise and promising project developments in Japan.

Vonex Limited reports operational improvements, low complaint rates, and strategic executive hires in Q4 FY25, alongside a pivotal acquisition agreement with MaxoTel.

oOh!media has confirmed that its contract with Auckland Transport, accounting for 4% of FY24 revenue, will not be renewed after September 2025. Despite this setback, the company remains confident in its New Zealand market position.

Top Shelf International Holdings is set to raise up to $10 million through convertible notes to support a strategic business restructure and operational improvements, alongside forging a key sales partnership with Amber Bev.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

GQG Partners reported a record US$172.4 billion in funds under management as of June 30, 2025, despite relative underperformance due to a defensive portfolio stance. Net inflows remain solid but show signs of moderation compared to last year.

Almonty Industries has announced a 1-for-1.5 share consolidation approved by shareholders to streamline its capital structure in preparation for a potential Nasdaq listing.